Cargando…
Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
Based on mucosal immunization to promote both mucosal and systemic immune responses, next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered intranasally or orally. The goal of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is to provide adequate imm...
Autores principales: | Miteva, Dimitrina, Peshevska-Sekulovska, Monika, Snegarova, Violeta, Batselova, Hristiana, Alexandrova, Radostina, Velikova, Tsvetelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523321/ https://www.ncbi.nlm.nih.gov/pubmed/36188733 http://dx.doi.org/10.5501/wjv.v11.i5.221 |
Ejemplares similares
-
COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination
por: Snegarova, Violeta, et al.
Publicado: (2022) -
Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
por: Ivanov, Nedelcho, et al.
Publicado: (2023) -
Gastrointestinal mucosal immunity and COVID-19
por: Velikova, Tsvetelina, et al.
Publicado: (2021) -
Pandemic control - do's and don'ts from a control theory perspective
por: Tomov, Latchezar, et al.
Publicado: (2022) -
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease
por: Peshevska-Sekulovska, Monika, et al.
Publicado: (2022)